<DOC>
	<DOCNO>NCT03013972</DOCNO>
	<brief_summary>Worldwide , nearly 1.25 million patient diagnosed 600,000 patient die colorectal cancer year . The third leading cause death colorectal cancer Taiwan 2012 . The current treatment colorectal cancer include surgery , chemotherapy and/or radiotherapy prescribe improve survival low risk recurrence . However , disease treatment-related toxicity cancer patient may result fatigue interfere quality life ( QoL ) . Previous study report cancer-related fatigue ( CRF ) common symptom experience patient stage disease , occur treatment , advanced disease disease-free survivor ; prevalence fatigue report 59-96 % patient undergoing chemotherapy , 65-100 % patient receive radiation therapy , 30 % long term survivor . Also , CRF report frequent distress toxicity colon rectal chemotherapy . The National Comprehensive Cancer Network ( NCCN ) publish guideline definition CRF `` persistent subjective sense physical , emotional , and/or cognitive tiredness exhaustion related cancer cancer treatment proportional recent activity significantly interfere usual functioning . '' Besides , CRF could dynamically change interaction among disease progression , treatment regimen , tumor site , nutrition , infection factor . Therefore , minimize impact CRF cancer patient , in-depth research CRF need . The aim longitudinal study examine dynamic change , correlate factor QoL CRF among colorectal cancer patient adjuvant chemotherapy . Furthermore , result supply physician understand CRF , help enhance quality cancer care perfect future .</brief_summary>
	<brief_title>A Longitudinal Study Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy</brief_title>
	<detailed_description>This study enroll colorectal cancer patient adjuvant chemotherapy 1 year ( estimate 60 patient ) . Brief fatigue inventory-Taiwanese form ( BFI-T ) functional assessment cancer therapy-general 7 ( FACT-G7 ) use evaluate patient ' fatigue quality life . Patients thoroughly inform aspect study activity schedule regulatory requirement must satisfy informed consent . Only patient give consent participate study meet inclusion exclusion criterion eligible enroll study . The questionnaire survey carry first chemotherapy treatment ( baseline ) , every four chemotherapy cycle ( i.e . cycle 4 , 8 12 ) chemotherapy treatment outpatient department ( OPD ) ward adjuvant chemotherapy treatment period . All patient receive standard chemotherapy continue 24 week ( 12 cycle ) disease progression , whichever come first . Subject demographic disease-related information also collect analysis .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>1 . Patients sign informed consent form 2 . Aged 20 year old 3 . Patients give diagnosis stage IIIV colorectal cancer 4 . Scheduled receive adjuvant chemotherapy 5 . Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¤ 2 6 . Able communicate verbally completely fill questionnaires 1 . Female patient pregnant breastfeed 2 . Patients enrol yet complete investigational drug trial within 30 day screen 3 . Patients give diagnosis cognitive impairment unable complete questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ColoRectal Cancer</keyword>
	<keyword>Adjuvant Chemotherapy</keyword>
	<keyword>Cancer-related Fatigue</keyword>
	<keyword>Brief fatigue inventory ( BFI )</keyword>
	<keyword>Functional Assessment Cancer Therapy-General 7 ( FACT-G7 )</keyword>
</DOC>